| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/27/1992 | CA2063850A1 Sulfated tocopheryl oligosaccharides and antiviral agents including the same as active ingredients |
| 09/27/1992 | CA2063170A1 Indole derivatives, preparation processes and medicinal products containing them |
| 09/23/1992 | EP0505135A2 Cholesterol lowering agents and antifungal agents |
| 09/23/1992 | EP0505123A1 Pulmonary administration of granulocyte colony stimulating factor |
| 09/23/1992 | EP0504919A2 Mirabilis jalapa antiviral protein |
| 09/23/1992 | EP0504871A1 Aranorosinol-A and Aranorosinol-B, a process for their production and their use |
| 09/23/1992 | EP0504290A1 Inhibitors of pneumocystis carinii dihydrofolate reductase. |
| 09/23/1992 | EP0504234A1 ANTIBODIES PREVENTING INTERACTION BETWEEN A FRAGMENT Fc OF AN IMMUNOGLOBULIN AND ITS RECEIVER, AND THERAPEUTIC USE, PARTICULARILY IN TREATING AFFECTIONS LINKED TO THE HIV VIRUS |
| 09/23/1992 | EP0504216A1 Cephalosporins, processes for their preparation, intermediates and pharmaceutical compositions containing them |
| 09/23/1992 | EP0504191A1 Method and composition for the treatment of mammalian hiv infection. |
| 09/23/1992 | EP0504186A1 Thiarubrine antifungal and antibiotic agents |
| 09/23/1992 | EP0504184A1 Active agent against retrovirus group viruses, compositions containing same and their use. |
| 09/23/1992 | EP0211899B1 Purification of native colony stimulating factor-1 |
| 09/23/1992 | CN1064701A Peroxyacid bleach precursor compositions |
| 09/22/1992 | WO1992016630A1 Dna sequences which code for virulence characteristics of streptococcus suis and parts thereof, polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by s. suis in mammals, including man |
| 09/22/1992 | WO1992016544A1 Novel derivative of caffeic acid, oraposide, cosmetic or pharmaceutical, particularly dermatological, composition containing it |
| 09/22/1992 | US5149718 Biological fluid purification system |
| 09/22/1992 | US5149707 1-((2-fluorophenyl)(4-fluorophenyl)phenylmethyl)-1h-imidazole useful as antifungal agent |
| 09/22/1992 | US5149653 By freeze-drying or drying in presence of stabilizer trehalose storage stability; used as immunogenic vaccines |
| 09/22/1992 | US5149530 Live newcastle disease virus vaccines |
| 09/22/1992 | US5149435 Molecular sieve arrangement and filtering method for removal of a selected constituent |
| 09/22/1992 | CA2102689A1 Novel caffeic acid derivative, oraposide, and cosmetic or pharmaceutic, especially dermatological, composition containing it |
| 09/22/1992 | CA1307740C Pharmaceutical preparation and method for inhibiting replication of htlv-iii (aids) virus |
| 09/19/1992 | CA2736076A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 09/19/1992 | CA2063230A1 Cholesterol lowering agents |
| 09/17/1992 | WO1992015693A1 Chimeric tar enzyme construction for hiv therapy |
| 09/17/1992 | WO1992015691A1 Biocidal proteins |
| 09/17/1992 | WO1992015689A1 Expression of recombinant proteins in attenuated bacteria |
| 09/17/1992 | WO1992015684A1 RECOMBINANT FIV GLYCOPROTEIN 160 AND p24 GAG PROTEIN |
| 09/17/1992 | WO1992015672A1 Genetically engineered vaccine strain |
| 09/17/1992 | WO1992015588A1 Esters of antibacterial condensed carbapeneme derivatives |
| 09/17/1992 | WO1992015582A1 1-SUBSTITUTED, 2-SUBSTITUTED 1H-IMIDAZO[4,5-c]QUINOLIN-4-AMINES |
| 09/17/1992 | WO1992015574A1 Novel quinolones, process for their preparation and pharmaceutical compositions containing same |
| 09/17/1992 | WO1992015328A1 Attenuated, genetically-engineered pseudorabies virus s-prv-155 and uses thereof |
| 09/17/1992 | WO1992015319A1 Hiv protease inhibitors |
| 09/17/1992 | WO1992015318A1 Use of cell surface receptor targeted molecules for the treatment of viral diseases |
| 09/17/1992 | WO1992015316A1 Modified proteins and their use for controlling viral infections |
| 09/17/1992 | WO1992015309A1 Antiviral nucleoside combination |
| 09/17/1992 | WO1992015308A1 Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis b |
| 09/17/1992 | CA2439322A1 Therapeutic nucleosides |
| 09/17/1992 | CA2106092A1 Biocidal proteins |
| 09/17/1992 | CA2104958A1 Use of cell surface receptor targeted molecules for the treatment of viral diseases |
| 09/16/1992 | WO1992016494A1 Long chain antiviral compounds |
| 09/16/1992 | WO1992016230A1 Lipid a analog/immunogenic carrier conjugates, the use thereof as vaccines and polyvalent hyperimmune gammaglobulins |
| 09/16/1992 | WO1992016207A1 USE OF OXAZOLO-[2,3-a]ISOINDOLE AND IMIDAZO[2,1-a]ISOINDOLE DERIVATIVES AS ANTIVIRAL DRUGS, AND NEW OXAZOLO[2,3-a]ISOINDOLE DERIVATIVES |
| 09/16/1992 | WO1992016192A1 Pulmonary administration of granulocyte colony stimulating factor |
| 09/16/1992 | EP0503988A1 Compositions to treat onychomycoses |
| 09/16/1992 | EP0503960A1 Cyclic lipopeptides having antibiotic activity |
| 09/16/1992 | EP0503949A1 Novel process for the preparation of 9-deoxo-9(z)-hydroxyiminoerythromycin A |
| 09/16/1992 | EP0503932A1 9-Deoxo-9(z)-hydroxy-iminoerythromycin A and O-derivatives thereof |
| 09/16/1992 | EP0503604A2 Allenyl beta-lactam compounds and process for preparing same |
| 09/16/1992 | EP0503520A1 Cyclic ketal derivatives |
| 09/16/1992 | EP0503453A2 New process for the production of cephalosporines and novel intermediates in this process |
| 09/16/1992 | EP0503252A2 Recombinant proteins having the immunoreactivity of Hepatitis B virus e antigens (HBeAg), method for their production and their application in immunoassays and as vaccines |
| 09/16/1992 | CN1064409A 无细胞马立克氏病病毒疫苗 Marek's disease virus acellular vaccine |
| 09/16/1992 | CN1064407A Pharmaceutical composition |
| 09/16/1992 | CA2108899A1 Use of oxazolo-[2,3-a]-isoindole and imidazo-[2,1-a]- isoindole derivatives as antiviral medicaments, as well as new oxazolo-[2,3-a]-isoindole derivatives |
| 09/16/1992 | CA2106068A1 Long chain antiviral compounds |
| 09/16/1992 | CA2105965A1 Lipid a analog/immunogenic carrier conjugates, the use thereof as vaccines and polyvalent hyperimmune gammaglobulins |
| 09/16/1992 | CA2063039A1 Use of phosphatidylserine and its derivatives in degenerative pathologies also associated with immune disfunctions |
| 09/16/1992 | CA2063018A1 Lipopeptide derivatives |
| 09/16/1992 | CA2062932A1 9-deoxo-9(z)-hydroxyiminoerythromycin a and o-derivatives thereof |
| 09/15/1992 | WO1992016643A1 Recombinant hybrid porin epitopes |
| 09/15/1992 | WO1992016627A1 Recombinant anticoccidial vaccine |
| 09/15/1992 | WO1992016508A1 Reissert compounds as anti-hiv agents |
| 09/15/1992 | US5147865 Phosphonopyrrolidine- and piperidine-containing pseudopeptides of the statin type, a process for their preparation and their use as medicaments against retroviruses |
| 09/15/1992 | US5147862 Administering a 1,3-glucan |
| 09/15/1992 | US5147858 Acidic polycyclic ether useful as an anticoccidial agent and as a growth promotant |
| 09/15/1992 | US5147853 Infection protectant |
| 09/15/1992 | US5147639 Type-c rotavirus cultures and uses therefor |
| 09/15/1992 | CA2106093A1 Recombinant anticoccidial vaccine |
| 09/15/1992 | CA2101335A1 Reissert compounds as anti-hiv agents |
| 09/14/1992 | WO1992016526A1 Thiazole derivatives |
| 09/14/1992 | CA2105981A1 Thiazole derivatives |
| 09/13/1992 | WO1992016530A1 Cyclic ketal derivatives |
| 09/13/1992 | CA2106072A1 Cyclic ketal derivatives |
| 09/10/1992 | CA2062410A1 Recombinant proteins with the immunoreactivity of hepatitis b virus e antigen (hbeag), a process for the preparation thereof and the use thereof in immunoassays and vaccines |
| 09/09/1992 | EP0502719A1 Plant polypeptides with inhibitory activity towards pathogenic microorganisms |
| 09/09/1992 | EP0502718A1 Natural and synthetic proteins with inhibitory activity towards pathogenic microorganisms |
| 09/09/1992 | EP0502690A2 Cyclopropane derivative |
| 09/09/1992 | EP0502661A2 Heteroanthracycline anti-tumor analogues |
| 09/09/1992 | EP0502468A1 Antibacterial condensed carbapenemes |
| 09/09/1992 | EP0502465A1 Esters of antibacterial condensed carbapenemederivatives |
| 09/09/1992 | EP0502464A1 Antibacterial condensed carbapenemes |
| 09/09/1992 | EP0502160A1 Aids therapy and vaccine |
| 09/09/1992 | EP0502100A1 Reduced-protein subunit vaccine for swine dysentery |
| 09/08/1992 | WO1992015587A1 Antibacterial condensed carbapenemes |
| 09/08/1992 | WO1992015586A1 Antibacterial condensed carbapenemes |
| 09/08/1992 | US5145951 Protected ologopeptides; treating aids |
| 09/08/1992 | US5145853 Bactericidal formulations for use in veterinary medicine |
| 09/08/1992 | US5145685 Skin treatment method and composition |
| 09/08/1992 | CA2105388A1 Antibacterial condensed carbapenemes |
| 09/08/1992 | CA2104777A1 Heterocyclic compounds |
| 09/08/1992 | CA1307256C Bbm-1675c and d antitumor antibiotics |
| 09/08/1992 | CA1307222C Thiadiazole antiviral agents |
| 09/08/1992 | CA1307206C Antibacterial agent for mammal use comprising cephalosporin derivatives as an effective ingredient |
| 09/05/1992 | CA2061862A1 Natural and synthetic proteins with inhibitory activity towards pathogenic microorganisms |
| 09/05/1992 | CA2061861A1 Plant polypeptides with inhibitory activity towards pathogenic microorganisms |
| 09/03/1992 | WO1992014823A1 Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis |
| 09/03/1992 | WO1992014751A1 Peptides for treatment |